Cancer research

Cancer research

Metastatic Hormone Refractory Prostate Cancer: Pipeline Insight and Emerging Therapies

Advanced-stage prostate cancer, known as metastatic hormone refractory prostate cancer (mHRPC), poses significant treatment challenges. The disease progresses despite anti-androgen treatments, resulting in cancer spreading to bones and lymph nodes. Symptoms include persistent bone pain, fatigue, weight loss, and urinary issues, which can significantly decrease patient quality of life. The

Cancer research

Jiangsu Cancer Hospital Launches Clinical Trial for Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Jiangsu Cancer Hospital has initiated a clinical trial to study the efficacy and safety of Apatolimab Tovolimab combined with regorafenib and paclitaxel as a second-line treatment for patients with advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma who have failed immunotherapy combined with chemotherapy. The open-label, multicenter phase II clinical